CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attack

The next committee discussion of this topic has been rescheduled to take place on 28 September 2023. Therefore, the discussion of this topic that was due to take place at the Diagnostics Advisory Committee (DAC) meeting on 27 July 2023 has been cancelled. This change to the timelines has been made to allow the External Assessment Group (EAG) time to complete further work in response to the comments on the draft guidance received during consultation.